Stocks on the move today: November 16, 2026
Market closed · Final, November 16, 2026 · Updated · official closing prices
The S&P 500 fell 1.9%, the Nasdaq Composite fell 2.5% and the Dow Jones fell 1.4% on November 16, 2026. The biggest moves: Summit Therapeutics Inc. (SMMT) −16.5% — Summit Therapeutics received a Complete Response Letter (CRL) from the FDA for ivonescimab, its lead lung…; CG Oncology Inc. (CGON) +14.0% — CG Oncology announced positive Phase 3 PIVOT-006 trial results for cretostimogene in intermediate-risk and…; AST SpaceMobile, Inc. (ASTS) −12.3% — Driven by a combination of broader space-sector weakness—with peers Rocket Lab and Firefly also…. 104 stocks in the tracked universe moved 5% or more.
Top gainers
| Ticker | Company | Move | Price | Vol vs avg | Why (one line) |
|---|---|---|---|---|---|
| CGON | CG Oncology Inc. | +13.95% | $84.78 | 9.0× · 9.9M | CG Oncology announced positive Phase 3 PIVOT-006 trial results for cretostimogene in intermediate-risk and high-grade Ta non-muscle-invasive bladder cancer, with the company stating it is the first therapeutic to demonstrate significant recurrence benefit in this patient population (web catalyst). |
| MOH | Molina Healthcare, Inc. | +11.27% | $233.09 | 1.9× · 1.8M | Molina Healthcare, Inc. (MOH) moved +9.34% from $213.17 to $233.09 on 2026-11-16, reaching a new 30-day high on significantly elevated volume (2.9x the 5-day average). |
| TSN | Tyson Foods, Inc. | +8.72% | $63.95 | 2.3× · 8.3M | Tyson Foods released fourth-quarter and fiscal 2026 financial results (Globe Newswire), missing earnings estimates per Zacks while guiding for a sales decline as the beef business remains under pressure (WSJ). source ↗ |
| HUBS | HubSpot, Inc. | +6.78% | $231.98 | 1.7× · 2.2M | After co-founder Brian Halligan returned as CEO, replacing Yamini Rangan, with the move also buoyed by the appointment of Adobe veteran Karen Burgess as incoming CFO (per web_catalyst and Google Finance). source ↗ |
| POWL | Powell Industries, Inc. | +5.94% | $151.20 | 3.4× · 2.5M | Ahead of fiscal Q4 2026 earnings scheduled for release after market close today (November 16), according to Google Finance and Yahoo Finance coverage. source ↗ |
| HNGE | Hinge Health, Inc. | +5.11% | $121.29 | 1.1× · 2.1M | We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. |
| CNC | Centene Corp. | +4.91% | $74.77 | 1.4× · 7.6M | No confirmed catalyst |
| TSCO | Tractor Supply Company | +4.12% | $37.95 | 1.2× · 15.3M | Tractor Supply Company (TSCO) moved +1.96% from $37.22 to $37.95 on 2026-11-16, reaching a new 30-day high on significantly elevated volume (2.1x the 5-day average). |
| ELV | Elevance Health Inc. | +3.86% | $446.28 | 1.7× · 2.3M | Driven by positive investor sentiment following management's 2027 growth guidance of at least 12% adjusted EPS growth (highlighted at recent investor conferences including UBS) and strengthening expectations for Medicaid margin recovery in 2027 as state regulators adjust reimbursement rates upward. source ↗ |
| STWD | Starwood Property Trust, Inc. | +3.62% | $11.75 | 1.9× · 12.2M | No confirmed catalyst |
Top losers
| Ticker | Company | Move | Price | Vol vs avg | Why (one line) |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | −16.47% | $11.82 | 4.8× · 24.4M | Summit Therapeutics received a Complete Response Letter (CRL) from the FDA for ivonescimab, its lead lung cancer drug, due to the absence of a statistically significant overall survival benefit in the HARMONi study—blocking the company's path to approval in its current form (Barron's, Benzinga). source ↗ |
| ASTS | AST SpaceMobile, Inc. | −12.33% | $28.58 | 1.2× · 21.9M | Driven by a combination of broader space-sector weakness—with peers Rocket Lab and Firefly also declining—and pre-conference caution ahead of an investor conference starting November 17 where the market expects concrete updates on commercial service timelines and the Rakuten venture (Benzinga). source ↗ |
| NTRA | Natera, Inc. | −9.59% | $288.48 | 1.2× · 2.3M | Following a stock sale by Eurizon Capital SGR S.p.A., as reported by defenseworld.net. source ↗ |
| TEM | Tempus AI, Inc. | −9.55% | $64.76 | 0.7× · 4.9M | As linked to company-specific moves reported on finance.yahoo.com. source ↗ |
| AAOI | Applied Optoelectronics, Inc. | −9.48% | $45.16 | 0.7× · 10.1M | We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. |
| ALAB | Astera Labs, Inc. Common Stock | −8.79% | $202.34 | 0.9× · 4.5M | Despite a announced collaboration with Hyve Solutions to accelerate AI inference capacity delivery (Globe Newswire). source ↗ |
| APLD | Applied Digital Corp. | −8.70% | $14.58 | 0.7× · 20.3M | Driven by a combination of sector-wide AI infrastructure weakness—including NVIDIA CEO Jensen Huang's departure and soft guidance from peer Nebius Group—alongside renewed scrutiny of APLD's customer concentration risk and debt-funded data center expansion. source ↗ |
| GLXY | Galaxy Digital | −8.62% | $13.14 | 1.2× · 9.9M | No confirmed catalyst |
| DOCN | DigitalOcean Holdings, Inc. | −8.62% | $78.88 | 0.8× · 2.9M | We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. |
| SNDK | Sandisk Corporation | −8.58% | $809.11 | 1.1× · 12.2M | As linked to AI chip–related developments (finance.yahoo.com). source ↗ |
Trending
Definition: highest session volume relative to the stock's 30-session average volume, minimum 1.5×. Not a measure of price direction.
| Ticker | Company | Move | Price | Vol vs avg | Why (one line) |
|---|---|---|---|---|---|
| CGON | CG Oncology Inc. | +13.95% | $84.78 | 9.0× · 9.9M | CG Oncology announced positive Phase 3 PIVOT-006 trial results for cretostimogene in intermediate-risk and high-grade Ta non-muscle-invasive bladder cancer, with the company stating it is the first therapeutic to demonstrate significant recurrence benefit in this patient population (web catalyst). |
| INGM | Ingram Micro Holding Corporation | −3.13% | $27.53 | 5.2× · 12.2M | We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific negative catalyst was found. |
| SMMT | Summit Therapeutics Inc. | −16.47% | $11.82 | 4.8× · 24.4M | Summit Therapeutics received a Complete Response Letter (CRL) from the FDA for ivonescimab, its lead lung cancer drug, due to the absence of a statistically significant overall survival benefit in the HARMONi study—blocking the company's path to approval in its current form (Barron's, Benzinga). source ↗ |
| CHYM | Chime Financial, Inc. Class A Common Stock | +2.21% | $34.29 | 3.9× · 16.0M | No confirmed catalyst |
| POWL | Powell Industries, Inc. | +5.94% | $151.20 | 3.4× · 2.5M | Ahead of fiscal Q4 2026 earnings scheduled for release after market close today (November 16), according to Google Finance and Yahoo Finance coverage. source ↗ |
| SOJE | Southern Company (The) Series 2 | −2.54% | $14.60 | 3.4× · 352K | We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. |
| CMSD | CMS Energy Corporation 5.875% Junior Subordinated Notes due 2079 | −2.23% | $18.86 | 2.6× · 289K | As today (November 16, 2026) marked the ex-dividend date for the security's $0.37 periodic distribution. source ↗ |
| TSN | Tyson Foods, Inc. | +8.72% | $63.95 | 2.3× · 8.3M | Tyson Foods released fourth-quarter and fiscal 2026 financial results (Globe Newswire), missing earnings estimates per Zacks while guiding for a sales decline as the beef business remains under pressure (WSJ). source ↗ |
| KDP | Keurig Dr Pepper Inc. | −2.09% | $35.58 | 2.3× · 43.0M | We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. |
| ARMK | Aramark | +2.65% | $55.37 | 2.2× · 6.8M | After reporting Q4 FY2026 earnings. |
Stock market today: S&P 500, Nasdaq, Dow
Index levels as of Nov 16, 2026, 6:08 PM ET · Final, November 16, 2026 · source: FMP.
Go deeper
- Summit Therapeutics (SMMT) Plunges ~16% to a 52-Week Low After the FDA Rejects Ivonescimab's First US Filing · November 16, 2026
- Tyson Foods (TSN) Jumps ~7% on a Better-Than-Feared Q4 and an Outlook for Sharply Narrower Beef Losses · November 16, 2026
- Black Hills and NorthWestern Complete Their Merger to Form Bright Horizon Energy (NYSE: HZN) · November 16, 2026
- Earnings calendar: who reports today and this week →
- Sector dashboard →
How this page is built
- Universe: ~1,000 US-listed large and mid caps tracked by BestStocks. Rows must have a price of at least $5, a market cap of at least $2B (where the cap is known from the latest quote), and session volume of at least 250K shares (50K pre-market). A quote must have traded in the session shown. ETFs and index funds are excluded.
- Moves: percent change versus the prior close. Intraday figures are FMP quotes captured every 10 minutes during the regular session (delayed up to 10 minutes); final figures are official closes from the daily price series. A move larger than 25% is shown only when a confirmed change event backs it.
- Reasons: each one-line reason is the ticker's own stored, source-cited explanation for this session — the same text that appears on its what changed page. When none exists the row says “No confirmed catalyst”; nothing is written without a source.
- Trending: session volume divided by the 30-session average volume, minimum 1.5×.
- Refresh: pre-market at ~8:30 and ~9:15 AM ET; every 10 minutes while the market is open; final figures after the 4:30 PM ET close process. Weekends and holidays show the last completed session, dated.
- Data source: Financial Modeling Prep (FMP) quotes and daily prices; company data from FMP profiles.